Phase 1/2 Randomized, Open-label, Multicenter, Simon Two-stage Study of Pelareorep Combined with Modified FOLFIRINOX +/- Atezolizumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Arnold, Dirk et al, Previously presented at the 2024 American Society of Clinical Oncology Annual Meeting; 2024 May 31 – June 4